Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Current semi-occluded vocal tract therapies limit the type of vocalizations that can be produced to single vowels, which does not promote learning of the healthy voice behavior in connected speech or generalization to conversation. However, recent preliminary results using a semi-occluded mask indicate that the use of certain mask port diameters may allow for natural speech production while increasing supraglottal pressure and impedance, and thereby result in elicitation of voice with increased efficiency. In addition, the use of a semi-occluded mask provides the possibility for a better transition from phonating single phonemes in therapy to training the target therapy techniques in connected speech.
Treatment of voice disorders varies but often involves voice therapy and/or surgical intervention. Voice therapy, a non-invasive behavioral treatment for voice disorders, helps patients develop beneficial voice habits, prevents recurrence of voice disorders, and facilitates long-lasting vocal improvement. Many voice therapy techniques involve a semi-occluded vocal tract (SOVT). SOVT treatment is often characterized by sustained (straw phonation, voiced fricatives, nasals), oral oscillatory (lip buzzes, tongue trills, raspberries) or transitory phonation (plosives and glides). Straw phonation therapy, one of the most utilized SOVT methods, was first proposed in 1904 and involved phonating at different pitches into small glass tubes with varying diameters and lengths providing simultaneous semi-occlusion and extension of the vocal tract. Voice therapy exercises involving voice production with a semi-occluded and sometimes lengthened vocal tract have demonstrated improved vocal efficiency and loudness, reduced mechanical trauma to the vocal fold mucosa, and improved source-filter interaction.Our group recently developed a semi-occluded facemask for use in patients with and without voice disorders. Recent preliminary results using this semi-occluded facemask indicated that the use of a certain mask port diameters may elicit voice with increased efficiency. A study of 5 participants without voice disorders revealed that a mask occlusion diameter of 6.4 and 3.2 mm resulted in improved vocal efficiency. A study of the immediate effects of a semi-occluded facemask in 20 patients with voice disorders revealed that occlusions diameters of 9.6, 6.4, and 3.2 mm all resulted in significant improvements in acoustic and aerodynamic voice outcomes.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Voice Disorder Requiring Voice Therapy | Other | Individuals with a voice disorder such as muscle tension dysphonia (MTD), vocal fold atrophy or vocal fold lesions recommended for voice therapy as treatment. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Inclusion of semi-occluded mask in voice therapy | Device | Patients will be given a facemask with a semi-occlusion (SOMask) for use during in person voice therapy and for use at home therapy practice. |
| Measure | Description | Time Frame |
|---|---|---|
| Change From Baseline in VHI-10 Score After 4 Sessions of Voice Therapy | VHI-10 is a 10 item, self reported, voice related outcome related to an individual's perception of their vocal quality and how it impacts their life. (Voice Handicap Index) Scale scores range from 0-40 where higher scores correspond to a worse vocal quality. | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
| Measure | Description | Time Frame |
|---|---|---|
| Change From Baseline in Cepstral Peak Prominence (dB) | CPP is an objective evaluation of voice recordings through specialized vocal analysis software. | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
| Change From Baseline in Cepstral Spectral Index of Dysphonia (CSID--a Multivariate Estimate of Dysphonia Severity) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15219 | United States |
Any data shared would be completely de-identified. Currently there is no plan to share information at this time.
Not provided
additional researchers may receive de-identified information only if a data use agreement has been executed.
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Voice Disorder Requiring Voice Therapy | Individuals with a voice disorder such as muscle tension dysphonia (MTD), vocal fold atrophy or vocal fold lesions recommended for voice therapy as treatment. Inclusion of semi-occluded mask in voice therapy: Patients will be given a facemask with a semi-occlusion (SOMask) for use during in person voice therapy and for use at home therapy practice. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Voice Disorder Requiring Voice Therapy | Individuals with a voice disorder such as muscle tension dysphonia (MTD), vocal fold atrophy or vocal fold lesions recommended for voice therapy as treatment. Inclusion of semi-occluded mask in voice therapy: Patients will be given a facemask with a semi-occlusion (SOMask) for use during in person voice therapy and for use at home therapy practice. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change From Baseline in VHI-10 Score After 4 Sessions of Voice Therapy | VHI-10 is a 10 item, self reported, voice related outcome related to an individual's perception of their vocal quality and how it impacts their life. (Voice Handicap Index) Scale scores range from 0-40 where higher scores correspond to a worse vocal quality. | Posted | Median | 95% Confidence Interval | score on a scale | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
|
approximately 6 weeks for each participant
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Voice Disorder Requiring Voice Therapy | Individuals with a voice disorder such as muscle tension dysphonia (MTD), vocal fold atrophy or vocal fold lesions recommended for voice therapy as treatment. Inclusion of semi-occluded mask in voice therapy: Patients will be given a facemask with a semi-occlusion (SOMask) for use during in person voice therapy and for use at home therapy practice. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Jacqueline Gartner-Schmidt | University of Pittsburgh | 412-232-8970 | jgs@pitt.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan: Study Protocol with Statistical Analysis Plan | Feb 11, 2020 | Nov 11, 2020 | Prot_SAP_001.pdf |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014832 | Voice Disorders |
| ID | Term |
|---|---|
| D007818 | Laryngeal Diseases |
| D012140 | Respiratory Tract Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D009461 | Neurologic Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CSID is an objective evaluation of voice recordings through specialized vocal analysis software. The CSID is a multifactorial estimate of vocal severity that correlates with the labeled visual analog scale for severity (in %). Normal cutoff range is from 19-24. Values outside of this range are considered to have varying degrees of dysphonia. The values are captured using specialized voice analysis equipment and analyzed using the specialized CSID software. Depending on the voice disorder, CSID can be calculated as both negative and positive integers with no true boundaries. |
| Baseline and approximately 6-8 weeks later; after completion of voice therapy |
| Change From Baseline in Mean Airflow in Milliliters (ml) During Reading of Standardized Paragraph | mean airflow will be captured during the phonatory aerodynamic system (PAS) recording of airflow during the reading of the standardized paragraph. | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
| Change From Baseline in Mean Vocal Intensity (dB) | mean vocal intensity will be captured during the phonatory aerodynamic system (PAS) recording of airflow during the reading of the standardized paragraph. | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
| Change in the Number of Breaths Taken During Reading of Standardized Paragraph | Numeric value of the number of breaths needed to complete the reading of a paragraph. Values are positive integers | Baseline to post treatment |
| Participants |
|
| Age, Continuous | Median | Full Range | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Voice Handicap Index - 10 | This is a self report questionnaire describing the quality of voice problems. Consists of 10 questions. Each question has a minimum value of 0 and a maximum value of 4. A score of 0 is the lowest overall score. A score of 40 is the maximum overall score. The higher the value, the greater the voice problem. | Mean | Full Range | units on a scale |
|
| Cepstral Peak Prominance-CPP | an objective, acoustic measure of voice quality that has been qualified as a robust acoustic measure of dysphonia severity | Mean | Full Range | decibels |
|
| Cepstral Spectral Index of Dysphonia (CSID) | CSID is an objective evaluation of voice recordings through specialized vocal analysis software. The CSID is a multifactorial estimate of vocal severity that correlates with the labeled visual analog scale for severity (in %). Normal cutoff range is from 19-24. Values outside of this range are considered to have varying degrees of dysphonia. The values are captured using specialized voice analysis equipment and analyzed using the specialized CSID software. CSID can be calculated as both negative and positive integers with no true boundaries | Mean | Full Range | units on a scale |
|
| Mean Airflow | Aerodynamic measure of airflow. Increased airflow leads to better voice mechanics and better voice quality. | Mean | Full Range | mL/s |
|
| Mean vocal intensity | Acoustic measure of voice | Mean | Full Range | dB SPL |
|
| Voice Diagnoses | Number | participants |
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Secondary | Change From Baseline in Cepstral Peak Prominence (dB) | CPP is an objective evaluation of voice recordings through specialized vocal analysis software. | Posted | Median | 95% Confidence Interval | dB | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
|
|
|
|
| Secondary | Change From Baseline in Cepstral Spectral Index of Dysphonia (CSID--a Multivariate Estimate of Dysphonia Severity) | CSID is an objective evaluation of voice recordings through specialized vocal analysis software. The CSID is a multifactorial estimate of vocal severity that correlates with the labeled visual analog scale for severity (in %). Normal cutoff range is from 19-24. Values outside of this range are considered to have varying degrees of dysphonia. The values are captured using specialized voice analysis equipment and analyzed using the specialized CSID software. Depending on the voice disorder, CSID can be calculated as both negative and positive integers with no true boundaries. | Posted | Median | 95% Confidence Interval | units on a scale | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
|
|
|
|
| Secondary | Change From Baseline in Mean Airflow in Milliliters (ml) During Reading of Standardized Paragraph | mean airflow will be captured during the phonatory aerodynamic system (PAS) recording of airflow during the reading of the standardized paragraph. | Posted | Median | 95% Confidence Interval | milliliters | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
|
|
|
|
| Secondary | Change From Baseline in Mean Vocal Intensity (dB) | mean vocal intensity will be captured during the phonatory aerodynamic system (PAS) recording of airflow during the reading of the standardized paragraph. | Posted | Median | 95% Confidence Interval | decibels | Baseline and approximately 6-8 weeks later; after completion of voice therapy |
|
|
|
|
| Secondary | Change in the Number of Breaths Taken During Reading of Standardized Paragraph | Numeric value of the number of breaths needed to complete the reading of a paragraph. Values are positive integers | This information was not collected during this study on any of the participants. Therefore, there was no data to analyze. | Posted | Baseline to post treatment |
|
|
| 0 |
| 11 |
| 0 |
| 11 |
| 0 |
| 11 |
Not provided
Not provided
Not provided
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |